Parkinson Disease
Conditions
Brief summary
This study aims to evaluate the validity and reliability of the Turkish version of the Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease.
Interventions
OTHERCognitive Self-Efficacy Questionnaire (Turkish Version)
Participants will complete the Turkish version of the Cognitive Self-Efficacy Questionnaire to assess cognitive self-efficacy. The questionnaire will be administered for the evaluation of its validity and reliability in individuals with Parkinson's disease.
Sponsors
Acibadem University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Able to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology, Istanbul Cerrahpaşa Faculty of Medicine Hospital * Able and willing to provide written informed consent
Exclusion criteria
* Major depressive disorder or psychotic disorder * Advanced dementia * Severe visual impairment that may interfere with study assessments * Severe hearing impairment that may interfere with study assessments * Inability to cooperate with the physiotherapist * Inability to complete the study assessments
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Validity and Reliability of the Turkish Version of the Cognitive Self-Efficacy Questionnaire (CSEQ) | Baseline and 14-21 days for test-retest assessment | Assessment of the psychometric properties of the Turkish version of the CSEQ in individuals with Parkinson's disease, including internal consistency (Cronbach's alpha), test-retest reliability (intraclass correlation coefficient), and construct validity through factor and correlation analyses. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self-Efficacy for Managing Chronic Disease (6-Item Scale) | Baseline | Assessment of perceived self-efficacy in managing chronic disease using the 6-Item Self-Efficacy for Managing Chronic Disease Scale. The scale evaluates individuals' confidence in managing symptoms such as pain, fatigue, emotional distress, and disease-related problems. It consists of 6 items scored on a 10-point Likert scale (1 = not at all confident, 10 = totally confident), with the total score calculated as the mean of all items. Higher scores indicate greater self-efficacy in disease management. The validated Turkish version will be used. |
| Montreal Cognitive Assessment (MoCA-TR) | Baseline | Cognitive function will be assessed using the Turkish version of the Montreal Cognitive Assessment (MoCA-TR). This screening tool evaluates multiple cognitive domains including visuospatial/executive functions, naming, attention, language, abstraction, delayed recall, and orientation. The total score ranges from 0 to 30, with higher scores indicating better cognitive function. The validated Turkish version for Parkinson's disease will be used. |
Countries
Turkey (Türkiye)
Contacts
CONTACTNuray ALACA
Outcome results
None listed